BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38724805)

  • 1. The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.
    Yap WK; Hsu KH; Wang TH; Lin CH; Kang CJ; Huang SM; Lin HC; Hung TM; Chang KP; Tsai TY
    Ann Nucl Med; 2024 May; ():. PubMed ID: 38724805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein-Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
    Shen EY; Hung TM; Tsan DL; Cheng NM; Kang CJ; Huang SF; Hsu CL; Lin CY; Wang HM; Hsieh JC; Cheng AJ; Fan KH; Chang JT
    Radiother Oncol; 2022 Dec; 177():1-8. PubMed ID: 35568282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma.
    Hung TM; Fan KH; Kang CJ; Huang SF; Lin CY; Ho AT; Wang HM; Hsieh JC; Cheng AJ; Ng SH; Chang JT
    Oral Oncol; 2020 Nov; 110():104756. PubMed ID: 32652479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
    Chen PJ; Yap WK; Chang YC; Tseng CK; Chao YK; Hsieh JC; Pai PC; Lee CH; Yang CK; Ho AT; Hung TM
    BMC Cancer; 2020 Jun; 20(1):545. PubMed ID: 32522275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node-to-primary tumor ratio of PET standardized uptake value for nasopharyngeal carcinoma: a recursive partitioning risk stratification analysis.
    Kong FF; Pan GS; Ni MS; Du CR; Hu CS; Ying HM
    Ther Adv Med Oncol; 2024; 16():17588359241233235. PubMed ID: 38379851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
    Lou Y; Chen D; Lin Z; Sun J; Song L; Chen W; Zhang M; Chen Y
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):347-356. PubMed ID: 35932312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic prediction using maximum standardized uptake value ratio of lymph node-to-primary tumor in preoperative PET-CT for oral squamous cell carcinoma.
    Ishibashi-Kanno N; Yamagata K; Hara T; Takaoka S; Fukuzawa S; Uchida F; Bukawa H
    J Stomatol Oral Maxillofac Surg; 2023 Oct; 124(5):101489. PubMed ID: 37146793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Utility of Neck Lymph Node-to-Primary Tumor Standardized Uptake Value Ratio in Oral Cavity Cancer.
    Ho KW; Fang KH; Lu CH; Hsu CM; Lai CH; Liao CT; Kang CJ; Tsai YH; Tsai MS; Huang EI; Chang GH; Ko CA; Tsai MH; Tsai YT
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment [
    Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
    Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
    Zhu D; Wang Y; Wang L; Chen J; Byanju S; Zhang H; Liao M
    Acta Radiol; 2018 Sep; 59(9):1082-1090. PubMed ID: 29256260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflecting on the utility of standardized uptake values on
    Qiu X; Wu H; Xu T; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Yi L; Li L; Liu J; Fei Z; Chen C
    BMC Cancer; 2022 May; 22(1):495. PubMed ID: 35513804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Lymph Node Burden in Oral Cavity Cancer: Systematic Review and Meta-Analysis.
    Tsai TY; Iandelli A; Marchi F; Huang Y; Tai SF; Hung SY; Kao HK; Chang KP
    Laryngoscope; 2022 Jan; 132(1):88-95. PubMed ID: 34089539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of primary tumor and lymph node volumetric metabolic parameters at pre-treatment F-18 FDG PET/CT in nasopharyngeal carcinoma.
    Demirel BB; Gülbahar Ateş S; Atasever Akkaş E; Göksel F; Uçmak G
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):367-373. PubMed ID: 37391092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.
    Lin MY; Wu M; Brennan S; Campeau MP; Binns DS; MacManus M; Solomon B; Hicks RJ; Fisher RJ; Ball DL
    J Thorac Oncol; 2014 Mar; 9(3):377-82. PubMed ID: 24518089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.